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Abstract: Mother-to-infant bonding is important for long-term child development. The aim of this
study was to investigate bonding in women admitted to a Mother and Baby Unit with postpartum
depression (PD, n = 64) and postpartum psychosis (PP, n = 91). Participants completed the Postpartum
Bonding Questionnaire (PBQ), the Edinburgh Postnatal Depression Scale (EPDS) and the Young
Mania Rating Scale (YMRS) weekly during admission. At admission, 57.1% of women with PD
had impaired bonding, compared to only 17.6% of women with PP (p-value < 0.001). At discharge,
only 18.2% of women with PD and 5.9% of women with PP still experienced impaired bonding
(p-value = 0.02). There was a strong association between decrease of depressive and manic symptoms
and improved bonding over an eight-week admission period. In a small group of women (5.7%)
impaired bonding persisted despite being in remission of their psychiatric disorder. The results
from our study show that impaired bonding is a more present and evidently severe problem in
postpartum depression but not so much in postpartum psychosis. Treatment of depressive symptoms
will improve bonding in almost all women, but clinicians should assess if impaired bonding is still
present after remission because for a small group special care and treatment focused on bonding
might be required.
Keywords: postpartum depression; postpartum psychosis; mother-to-infant bonding; attachment;
mother baby unit; mania; postnatal
1. Introduction
Affective and protective feelings towards the child usually begin during the first trimester of
pregnancy [1]. These feelings gradually increase during pregnancy, particularly in response to fetal
movements [2]. After giving birth, the term “bonding” refers to the unidirectional feelings experienced
by a mother towards her child [3]. Mother-to-infant bonding is considered to form the foundation
for the child’s later attachment [4]. The development of bonding is important, as impaired bonding
can impact the child’s emotional, cognitive, and behavioral long-term development. For example,
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studies have shown associations between impaired mother-to-infant bonding and child behavior
problems in early childhood [5], and an increased child’s risk of developing psychopathology in
adulthood [6]. Moreover, mothers who reported impaired mother-to-infant bonding experienced high
levels of parenting stress during toddlerhood [7], and these children are at risk for maltreatment later
in life [8]. While in most situations adequate bonding develops gradually after birth, bonding can be
impaired when the mother suffers from a psychiatric disorder [8].
The postpartum period is considered a time of increased risk for the development of severe
psychiatric disorders [9]. Postpartum depression (PD) is one of the most common disorders and
affects approximately 10% of new mothers [10]. A less common but more severe postpartum illness is
postpartum psychosis (PP). Postpartum psychosis is the umbrella term for postpartum mania, psychosis,
and depression with psychotic features [11]. First onset postpartum psychosis has an incidence ranging
from 0.24 to 0.6 women per 1000 births [12–14]. The prevalence of PP in women with a prior diagnosis
of bipolar disorder is high, our meta-analysis reported 17% [15]. Given the severity of the illness
and the high relative risk for suicide and infanticide, early recognition and adequate treatment is of
great importance [16,17]. Both severe PD and PP are indications for psychiatric hospitalization [12,18].
Joint inpatient mother–baby admission to a Mother and Baby Unit (MBU) is preferred for PP and
PD, as these admissions are associated with reduced time to recovery, when opposed to mother-only
admission [19–21]. With an adequate treatment regime, nearly all women with postpartum mood
disorders achieve full remission [22].
While the association between PD and impaired bonding is well established in current
literature [3,23–27], there is hardly any research on the association between PP and impaired bonding.
As the underlying nature of PD and PP differ substantially, it is uncertain whether the magnitude of
the problem is comparable in both groups. In addition, previous studies have not investigated how the
relationship between PD/PP and impaired bonding is affected by the treatment of the depressive and
manic symptoms. Acquiring this data could provide insights into driving factors behind impaired
bonding and underline the importance of particular treatment regimens. In this inpatient study
on a Mother and Baby Unit (MBU), we therefore examined the differences in mother-to-infant
bonding between women with postpartum psychosis and women with severe postpartum depression.
Additionally, we investigated the association between change in depressive and manic symptoms and
mother-to-infant bonding scores over the course of MBU admission.
2. Methods
2.1. Study Design and Participants
The present study was embedded in an ongoing prospective multicenter cohort study (OPPER),
which focuses on the prevention, treatment, and neurobiology of peripartum mood disorders [22,28].
Women are eligible for this study if they (a) are between 18–45 years of age, (b) have a postpartum
onset of psychosis, mania, or severe depression as assessed with the Structured Clinical Interview
for DSM-IV Axis I disorders (SCID) [29], and (c) are admitted to the MBU. Exclusion criteria are:
(a) prenatal onset of psychosis, mania or severe depression, (b) drug/alcohol dependence in the last
3 months, (c), intellectual disability (IQ < 80), (d) serious somatic illness and (e) inability to read or
write. The Medical Ethical Committee of the Erasmus Medical Center Rotterdam approved the study
(MEC-2005226). Written informed consent was obtained from all participants.
For the current study, all women who participated in OPPER between May 2005 and January 2013,
and who had completed a Postpartum Bonding Questionnaire (PBQ) [30], were included.
2.2. Data Collection and Procedures
Psychiatric diagnosis was established at intake using the SCID [29]. Bonding was measured with
the Postpartum Bonding Questionnaire (PBQ) [30]. The PBQ is a self-report instrument that consists of
25 statements that are rated on a 6-point Likert scale (from “always” to “never”). It has four scales
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representing (1) impaired bonding, (2) rejection and anger, (3) anxiety about care, and (4) risk of abuse.
The maximum total score is 125 with a cut-off of 26 to identify mothers with medium impaired bonding
and a cut-off of 40 for mothers with severe impaired bonding. Depressive symptoms were measured
with the widely-used Edinburgh Postnatal Depression Scale (EPDS) [31]. A score of 13 or higher is
indicative of depressive disorder [31,32]. Manic symptoms were measured using the Young Mania
Rating Scale (YMRS) [33], a well-validated 11-item interviewer rated scale designed to assess the
severity of manic symptoms in bipolar patients. A state of euthymia usually requires a score below the
cut-off of 12 [34]. During hospitalization, the PBQ and EPDS were completed weekly by the participant
and the YMRS was completed weekly by a trained rater.
2.3. Treatment
Women in this study received pharmaceutical treatment according to medical guidelines,
as described previously [35]. Women with PP were treated with antipsychotics and/or lithium,
while women with PD were treated with either tricyclic antidepressants or a selective serotonin reuptake
inhibitor. In addition, non-pharmacological interventions to optimize mother–baby interaction took
place as part of the regular program of the MBU. These interventions included guidance from nursing
staff, video interaction guidance, baby massage and a support group for mothers. Women with PD and
PP were equally exposed to these interventions. Information on the effect of each individual treatment
intervention on mother-to-infant bonding was not collected in this observational study.
2.4. Statistical Analysis
Descriptive statistics of the study population are provided. Differences in demographic and clinical
characteristics between the PD and the PP group were tested using t-tests, Mann-Whitney U tests,
chi-square tests and Fisher’s exact test. We then tested differences in PBQ scores (both dichotomized
using the cut-off score of 26 and the cut-off score of 40) between women with PD and women with PP
at admission and at discharge, using chi-square tests and Fisher’s exact test. Additionally, we tested
whether bonding scores showed a different course during the MBU admission period for PD and PP
women by testing a diagnosis*time interaction term using linear mixed effect modelling analysis (LMM,
fixed intercept, fixed slope, AR(1), covariance matrix, maximum likelihood estimation). To examine the
association between change in depressive and manic symptoms and bonding scores over the course of
MBU admission, we used linear mixed effects modelling as well. This model ensures optimal use of the
weekly repeated assessments over the course of admission [36]. Because depressive symptoms were
present in both the PP and the PD groups, we tested the association between depressive symptoms
and bonding in both groups separately. Manic symptoms are, by definition, exclusively present in the
PP group. We therefore tested the association between manic symptoms and bonding in the PP group
only. Analyses were adjusted for maternal age and primiparity [16,37–39]. We report coefficients
and their confidence intervals. To visualize these associations, we created graphs displaying mean
EPDS, YMRS, and PBQ scores over the first eight weeks of admission in both the PD and the PP group.
We chose to display eight weeks as this was the mean length of admission. Statistical Package for
Social Sciences (SPSS) version 24.0 was used for data analysis. All hypotheses were tested with an
alpha of 0.05 (two-sided).
3. Results
Participants were 155 women with a severe postpartum mood disorder, of which 91 were diagnosed
with postpartum psychosis and 64 were diagnosed with postpartum depression. Relevant demographic
and clinical characteristics are presented in Table 1. Infant age at admission was significantly higher
for women with PD compared to women with PP. As expected, depressive symptoms (EPDS) were
higher in women with PD. There were no substantial differences in maternal age, length of admission,
relationship status, education level, gender of the infant and psychiatric history of the women.
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Table 1. Demographic and clinical characteristics.
Postpartum Psychosis
(n = 91)
Postpartum
Depression (n = 64) p-Value
Maternal age at admission (yr), mean (SD) 31.0 (4.7) 30.0 (8.0) 0.32
Length of admission (wks), mean (SD) 7.9 (4.3) 7.5 (4.8) 0.52
Dutch nationality, n (%) 83 (92.2) 55 (90.2) 0.66
Relationship, yes, n (%) 88 (97.8) 55 (93.2) 0.21
Primary/Secondary education only, n (%) 44 (48.4) 33 (60.0) 0.17
Primiparous, n (%) 68 (78.2) 40 (64.5) 0.09
Psychiatric history, n (%)
None 44 (48.4) 25 (39.1) 0.14
Prior postpartum episode 11 (12.1) 4 (26.7)
Prior non-postpartum episode 36 (39.6) 35 (54.7)
EPDS score at admission, mean (SD) 14.9 (6.0) 19.0 (4.9) 0.001 *
YMRS score at admission, mean (SD) 17.7 (11.5) n.a. n.a.
Family history of psychiatric disorder, n (%) 51 (56.0) 20 (35.0) 0.013 *
Infant age at admission (wks), median (IQR) 2.0 (3.7) 6.0 (5.2) <0.001 *
Gender infant, male, n (%) 45 (50.0) 26 (43.3) 0.51
* = Significant result (p < 0.05).
3.1. Prevalence of Impaired Mother-to-Infant Bonding at Admission and Discharge
At admission, 17.6% of women with PP compared to 57.1% of women with PD had a PBQ score
above the cut-off of 26 (p-value < 0.001), which is associated with medium to severe impaired bonding
(Figure 1). At discharge, only 5.9% of women with PP compared to 18.2% of women with PD still had
a PBQ score above this cut-off (p-value = 0.02).
The percentage of women with severe impaired bonding (PBQ score above the cut-off of 40)
at admission in women with PP was 5.9% compared to 37.5% in women with PD (p-value < 0.001).
At discharge, these percentages decreased to 1.2% in women with PP compared to 5.5% in women
with PD (p-value = 0.30). Mean PBQ scores during the first eight weeks of admission per group can be
seen in Figure 2. The PBQ scores went down gradually during the first five weeks of MBU admission
for both PP and PD patients, but showed no further decline up to eight weeks of admission. Formal
testing showed that the course of bonding problems during the admission period differed significantly
between PP and PD women (F(672) = 8.632; p = 0.003).
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Figure 1. Proportion of women with PP and PD presenting with medium to severe impaired bonding
at hospital admission and discharge; * = Significant result (p < 0.05); Abbreviations: PP = postpartum
psychosis; PD = postpartum depression; Note: PBQ scores were missing at random at both time-points.
During admission PP (n = 68)/PD (n = 56), at discharge PP (n = 85)/PD (n = 55).
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Figure 2. Change in mean mother-to-infant bonding scores and depressive (EPDS) and manic
(YMRS) symptoms in women with postpartum psychosis and postpartum depression (including
standard error bars). Abbreviations: PP = postpartum psychosis; PD = postpartum depression; PBQ:
Postpartum Bonding Questionnaire; Y RS = Young ania Rating Scale; EPDS = Edinburgh Postnatal
Depression Scale.
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EPDS score in the PD group was 19.0 (SD 4. ) and 1 (SD 6.0) in the PP group, which decreased to
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improvement of bonding was seen in the PP group (Figure 2c). In addition, we found a significant
association between a decrease i ma ic symptoms and improvement of bonding in PP patients
(Figure 2b), independent from the association with depressive symptoms. However, the correlation
between depressive symptoms and impaired mother-to-infant bonding was much stronger (compared
to the correlation between manic symptoms and impaired mother-to-infant bonding).
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Table 2. The effect of depressive (EPDS) and manic (YMRS) symptoms on mother-to-infant
bonding (PBQ).
Fixed Effects Unadjusted Estimate Sig. Adjusted Estimate Sig.
Linear mixed effects model in PP group
Intercept 2.62 0.02 7.96 0.22
EPDS 0.76 0.00 0.76 0.00
YMRS 0.16 0.02 0.16 0.02
Linear mixed effects model in PD group
Intercept 8.30 0.00 1.98 0.88
EPDS 1.05 0.00 1.05 0.00
Abbreviations: PP = postpartum psychosis; PD = postpartum depression; EPDS = Edinburgh Postnatal Depression
Scale; YMRS = Young Mania Rating Scale; PBQ = Postpartum Bonding Questionnaire. Adjusted estimates: adjusted
for maternal age and primiparity.
4. Discussion
4.1. Differences in Bonding Problems between PP and PD
In this prospective cohort study, we found that impaired mother-to-infant bonding is a major
problem in inpatient women with severe postpartum depression (57.1%), while less than 1 out 5 women
with postpartum psychosis reported impaired bonding (17.6%).
Moreover, in women with postpartum depression we found a higher proportion with severe
impaired bonding compared to women with PP. This is in line with previous research, which reports
that depressed mothers perceived their bonding to the baby more negatively than psychotic mothers
during admission [40]. In this study, they observed impaired bonding rates in 61.1% of women with
PD and 29.4% of women with PP. We agree with Hornstein et al. [40] that this intergroup difference is
an expression of the nature of the psychopathology. Mothers with PD have feelings of inadequacy,
negative cognitions, and self-doubt resulting in a negative bonding experience, while most mothers
with PP lack these cognitions, especially if they mainly have manic symptomatology.
At discharge, the number of women reporting impaired bonding had greatly reduced in both
groups (5.9% in PP vs. 18.2% in PD). Studies on impaired bonding in the general population have
shown prevalence rates from 12.2% at 48 hours postpartum [41] to 7.1% and 8.9% at 2 and 12 weeks
postpartum respectively [42,43]. Thus, the prevalence rate of impaired bonding at discharge in women
with a diagnosis of PP could be considered equal to that of the general population.
4.2. The Effect of Treating Depressive and Manic Symptoms on Mother-to-Infant Bonding
A recent systematic review identified 29 previous cross-sectional studies that investigated the
correlation between depressive symptoms and postnatal mother-to-infant bonding [27]. Out of these
29 studies, 21 studies observed a moderate to strong correlation (r = −0.61 to −0.14, ß = −0.39 to −0.26).
None of these studies examined the correlation over time. In our longitudinal study, we observed
the correlation between depressive symptoms and mother-to-infant bonding over time, and found an
almost exact concordant movement of both scores over an 8-week admission period. This indicates
that improvement in mother-to-infant bonding is highly dependent on improvement of depressive
symptoms. Impaired bonding seems to be an integral part of postpartum depression and could
therefore be an indication of the presence of a postpartum depression. We also found a correlation
between manic symptoms and mother-to-infant bonding over time, although this correlation was
much weaker.
In a small group of women (5.7%), impaired bonding persisted despite effective treatment of the
depressive and/or manic symptoms. This finding is in agreement with the earlier observations by other
researchers [3,8,44], and with reported prevalence rates of impaired bonding in the general population,
which suggest that impaired bonding can exist independent of psychiatric symptoms. Therefore,
at discharge, and also when patients are in remission, the quality of the mother-to-infant bonding
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should be assessed. For these women, besides treatment of their psychiatric disorder, interventions
aimed at improving bonding are important.
4.3. Strengths and Limitations
Although the findings should be interpreted with caution, this study has several strengths. This is
the first prospective cohort study to investigate the association of longitudinal depressive and manic
symptoms (at the symptom level) with mother-to-infant bonding in patients admitted with postpartum
psychosis or severe postpartum depression. Another strength of this study is the use of the PBQ [30],
an extensive screening instrument, assessing all domains of bonding. Nonetheless, the current study
also has several limitations. Differentiation between the most effective interventions for impaired
bonding could not be established, because inpatient treatment at the MBU included both interventions
aimed at reducing depressive, manic and/or psychotic symptoms, and interventions focused on
optimizing the mother–baby interaction. However, our positive results for improvement on both
domains underline the added value of joint inpatient mother–baby admission to an MBU as opposed
to mother-only admission. Furthermore, we encountered missing data points for measurements
during admission. Fortunately, mixed models allow data for all subjects to be included in the analysis
regardless of whether they completed all study time points.
4.4. Clinical Implications
The results from our study implicate that women with severe postpartum psychiatric disorders,
and especially women with severe postpartum depression, are at risk of impaired mother-to-infant
bonding due to the nature of their symptoms. While both manic and depressive symptoms were
strongly associated with impaired bonding, the association with depressive symptoms was stronger
both in the PD and the PP groups. Over the course of eight weeks of inpatient mother–baby admission at
our Mother and Baby Unit (MBU), the combined pharmacological and non-pharmacological treatment
greatly improved both depressive and manic symptoms and mother-to-infant bonding. While these
results are encouraging, admission to an MBU is only reserved for mothers with severe postpartum
psychiatric disorders and contingent on the presence of an MBU. Many women with mild to moderate
symptoms of depression will go undetected and untreated, or will receive treatment untailored to the
postpartum period, posing a threat to adequate mother-to-infant bonding, putting the child at risk for
adverse short- and long-term outcomes. Our findings support the necessity to establish MBUs, or at
least tailored treatment programs, for optimal patient care. Since the prevalence of prenatal depression
is similar or even higher than postpartum depression [45–47], and mother-to-infant bonding already
starts in the first trimester of pregnancy, we strongly encourage that diagnosis and interventions should
take place as early as possible during the perinatal period to avoid harmful consequences. Screening
for depression during pregnancy and the postpartum period is unfortunately not yet standard clinical
practice in many settings. Interventions should primarily be focused on the treatment of the psychiatric
disorder. Nonetheless, after remission has been achieved, it is important to check for residual impaired
bonding and to act accordingly.
4.5. Implications for Future Research
The results from our study indicate that mother-to-infant bonding is a major problem in women
with postpartum psychiatric disorders, especially in women with severe PD. Our data suggests that
treatment of depressive symptoms improves mother-to-infant bonding in almost all women. There is an
urgent need for studies comparing improvement in psychiatric symptomatology and mother-to-infant
bonding in MBU settings compared to regular outpatient treatment settings. In addition, longer
follow-up studies in women with impaired mother-to-infant bonding should be initiated and include
measurements of the cognitive and emotional development of the child, to investigate the long-term
effect of impaired bonding on the offspring later in life.
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